The wearable, cuffless, over-the-counter (OTC) device utilizes photoplethysmography, an optical sensor technology to collect data from the user’s wrist. The data is then sent to the Hilo App where it ...

Boston Scientific Corporation (NYSE: BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific ...

Emerging economies like India and China are becoming high-growth hotspots. The global pulse oximeters market is expected to ...

Johnson & Johnson MedTech today announced FDA approval for an update to its Varipulse platform's irrigation flow rate.

Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 7, Boston Scientific Corporation (NYSE:BSX) announced that it has obtained approval to expand ...

Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

What's powering an $7.03 billion global pulse oximeter opportunity? The global pulse oximeters market, valued at US$3.59 billion in 2024 ...

Masimo MightySat® Medical has received FDA clearance, making it the first and only FDA-cleared medical fingertip pulse oximeter available OTC.

Technology limitations Pulse oximeters are a quick, painless and affordable way to measure one of the most critical vital signs in emergency and non-emergency situations.

In this article, we discuss the problem that racial bias in pulse oximetry poses, the pressure on the FDA to address that bias, and the prospects for its near-term resolution.